EOLS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Evolus Inc

NASDAQ | EOLS

7.03

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$456.33M

Market Cap

-

P/E Ratio

-0.91

EPS

$17.12

52 Week High

$5.71

52 Week Low

HEALTHCARE

Sector

EOLS Chart

Recent Chart
Price Action

EOLS Technicals

Tags:

EOLS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $182M
Total Revenue $266M
Cost Of Revenue $84M
Costof Goods And Services Sold $84M
Operating Income -$34M
Selling General And Administrative $189M
Research And Development $9.2M
Operating Expenses $217M
Investment Income Net -
Net Interest Income -$15M
Interest Income $3.3M
Interest Expense $19M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6M
Income Before Tax -$50M
Income Tax Expense $664K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$31M
Ebitda -$25M
Net Income -$50M

Revenue & Profitability

Earnings Performance

EOLS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $233M
Total Current Assets $151M
Cash And Cash Equivalents At Carrying Value $87M
Cash And Short Term Investments $87M
Inventory $12M
Current Net Receivables $48M
Total Non Current Assets $81M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $49M
Intangible Assets Excluding Goodwill $49M
Goodwill $21M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $4.6M
Other Non Current Assets -
Total Liabilities $227M
Total Current Liabilities $63M
Current Accounts Payable $9.2M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7M
Total Non Current Liabilities $164M
Capital Lease Obligations $8.5M
Long Term Debt $122M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $130M
Other Current Liabilities $38M
Other Non Current Liabilities -
Total Shareholder Equity $5.5M
Treasury Stock -
Retained Earnings -$609M
Common Stock $1K
Common Stock Shares Outstanding $62M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$18M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6M
Capital Expenditures $1.5M
Change In Receivables -
Change In Inventory $3.3M
Profit Loss -
Cashflow From Investment -$4.8M
Cashflow From Financing $47M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$50M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $182M
Total Revenue $266M
Cost Of Revenue $84M
Costof Goods And Services Sold $84M
Operating Income -$34M
Selling General And Administrative $189M
Research And Development $9.2M
Operating Expenses $217M
Investment Income Net -
Net Interest Income -$15M
Interest Income $3.3M
Interest Expense $19M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6M
Income Before Tax -$50M
Income Tax Expense $664K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$31M
Ebitda -$25M
Net Income -$50M

EOLS News

EOLS Profile

Evolus Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Evolus, Inc. is an innovative aesthetic medical company headquartered in Newport Beach, California, dedicated to providing cutting-edge beauty solutions for healthcare providers and their patients. The company’s flagship product, Jeuveau, is a neurotoxin specifically formulated for the cosmetic market, reflecting Evolus's commitment to high-quality and effective aesthetic enhancements. With a strategic focus on expanding its product offerings and entering new markets, Evolus is positioned as a leader in the growing aesthetic industry, committed to advancing beauty standards and meeting the evolving needs of consumers.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
SNDK
+4.28%
$224.25
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
IVP
-9.12%
$0.12
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
SNDK
+4.28%
$224.25
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
IVP
-9.12%
$0.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.